1. Home
  2. TBPH vs ODD Comparison

TBPH vs ODD Comparison

Compare TBPH & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.40

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

ODD

ODDITY Tech Ltd.

HOLD

Current Price

$12.39

Market Cap

688.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
ODD
Founded
2013
2018
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
824.9M
688.4M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
TBPH
ODD
Price
$16.40
$12.39
Analyst Decision
Buy
Hold
Analyst Count
6
11
Target Price
$18.40
$41.00
AVG Volume (30 Days)
286.4K
1.3M
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
279.13
N/A
EPS
N/A
N/A
Revenue
$15,386,000.00
N/A
Revenue This Year
$8.46
N/A
Revenue Next Year
N/A
$22.92
P/E Ratio
N/A
$16.73
Revenue Growth
N/A
N/A
52 Week Low
$9.10
$10.80
52 Week High
$21.03
$79.18

Technical Indicators

Market Signals
Indicator
TBPH
ODD
Relative Strength Index (RSI) 46.74 35.09
Support Level $16.14 $10.80
Resistance Level $17.21 $16.04
Average True Range (ATR) 0.38 0.87
MACD -0.07 -0.13
Stochastic Oscillator 29.31 15.87

Price Performance

Historical Comparison
TBPH
ODD

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

About ODD ODDITY Tech Ltd.

ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.

Share on Social Networks: